Septerna, Inc. Common Stock Asset Resilience Ratio
Septerna, Inc. Common Stock asset resilience ratio. Septerna, Inc. Common Stock (SEPN) has an Asset Resilience Ratio of 48.41% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Septerna, Inc. Common Stock defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Septerna, Inc. Common Stock (2023–2025)
Asset resilience ratio of Septerna, Inc. Common Stock from 2023 to 2025. This chart shows how Septerna, Inc. Common Stock's Asset Resilience Ratio has changed over time. Read total liabilities of Septerna, Inc. Common Stock for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Septerna, Inc. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Septerna, Inc. Common Stock.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $275.80 Million | 48.41% |
| Total Liquid Assets | $275.80 Million | 48.41% |
Asset Resilience Insights
- Very High Liquidity: Septerna, Inc. Common Stock maintains exceptional liquid asset reserves at 48.41% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Septerna, Inc. Common Stock Industry Peers by Asset Resilience Ratio
Compare Septerna, Inc. Common Stock's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
Biotechnology | 62.31% |
|
Verona Pharma plc
F:I9SA |
Biotechnology | 0.00% |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
Biotechnology | 33.37% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
Biotechnology | 8.08% |
|
Bavarian Nordic
CO:BAVA |
Biotechnology | 10.83% |
|
Hebei Changshan Biochem Pharma
SHE:300255 |
Biotechnology | -0.03% |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
Biotechnology | 37.31% |
Septerna, Inc. Common Stock Asset Resilience Ratio by Year (2023–2025)
Septerna, Inc. Common Stock asset resilience ratio by year from 2023 to 2025. The table below shows the annual Asset Resilience Ratio data for Septerna, Inc. Common Stock.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 45.35% | $270.37 Million | $596.19 Million | +20.66pp |
| 2024-12-31 | 24.69% | $112.73 Million | $456.55 Million | -- |
| 2023-12-31 | 0.00% | $0.00 | $130.87 Million | -- |
About Septerna, Inc. Common Stock
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 … Read more